Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Oncolytics Biotech is a biotechnology business based in the US. Oncolytics Biotech stocks (ONCY.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $2.55 – a decrease of 8.14% over the previous week. Oncolytics Biotech employs 29 staff and has a market cap (total outstanding stock value) of $110.2 million.
Finder Award
Interactive Brokers
National Bank Direct Brokerage
| Latest market close | $1.58 |
|---|---|
| 52-week range | $0.80 - $2.28 |
| 50-day moving average | $1.44 |
| 200-day moving average | $1.50 |
| Wall St. target price | $6.92 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.32 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $1.58 from 2023-06-08
| 1 week (2023-06-02) | -8.14% |
|---|---|
| 1 month (2023-05-10) | -3.07% |
| 3 months (2023-03-10) | 27.42% |
| 6 months (2022-12-09) | -6.51% |
| 1 year (2022-06-08) | 39.82% |
|---|---|
| 2 years (2021-06-10) | -47.16% |
| 3 years (2020-06-10) | 2.16 |
| 5 years (2018-06-08) | 6.97 |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -42.85% |
| Return on equity TTM | -80.61% |
| Profit margin | 0% |
| Book value | $0.40 |
| Market capitalisation | $110.2 million |
TTM: trailing 12 months
We're not expecting Oncolytics Biotech to pay a dividend over the next 12 months.
Oncolytics Biotech's shares were split on a 10:95 basis on 24 May 2018. So if you had owned 95 shares the day before before the split, the next day you'd have owned 10 shares. This wouldn't directly have changed the overall worth of your Oncolytics Biotech shares – just the quantity. However, indirectly, the new 850% higher share price could have impacted the market appetite for Oncolytics Biotech shares which in turn could have impacted Oncolytics Biotech's share price.
Over the last 12 months, Oncolytics Biotech's shares have ranged in value from as little as $0.8 up to $2.28. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Oncolytics Biotech's is 1.7882. This would suggest that Oncolytics Biotech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Oncolytics Biotech Inc. , a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. The company is developing pelareorep, an intravenously delivered immunotherapeutic agent, which is in phase 3 clinical trial for the treatment of hormone receptor-positive / human epidermal growth factor 2-negative metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma. Oncolytics Biotech Inc. has a co-development agreement with Merck KGaA and Pfizer Inc. to co-develop pelareorep in combination with paclitaxel and Bavencio, a human anti-PD-L1 antibody for the treatment of hormone receptor-positive/human epidermal growth factor 2-negative metastatic breast cancer. The company was incorporated in 1998 and is headquartered in Calgary, Canada.
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.
This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).
This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).
This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).
This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).
This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).
This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).
This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).
This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).
This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).
